ophthalmologytimes23h
Bausch + Lomb provides update on potential sale
The announcement comes after a request was made by the Canadian Investment Regulatory Organization (CIRO) to explore the ...
Bausch Health downgraded to Hold from Buy at Jefferies
Jefferies downgraded Bausch Health (BHC) to Hold from Buy.Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' ...
Bausch Health downgraded at Jefferies with B+L deal catalyst removed
Jefferies analyst Glen Santangelo downgraded Bausch Health (BHC) to Hold from Buy with a price target of $8, down from $12, after the company ...